Dal Santo, Francesco
González-Blanco, Leticia
García-Álvarez, Leticia
de la Fuente-Tomás, Lorena
Velasco, Ángela
Álvarez-Vázquez, Clara María
Martínez-Cao, Clara
Sáiz, Pilar A.
García-Portilla, María Paz
Bobes, Julio
Funding for this research was provided by:
Instituto de Salud Carlos III (PI13/02263)
Article History
Received: 15 March 2020
Accepted: 4 September 2020
First Online: 29 September 2020
Competing interets
: FDS has received grants from the Spanish Foundation of Psychiatry and Mental Health. LGB has been a consultant to and/or has received honoraria/grants from the Spanish Foundation of Psychiatry and Mental Health, European Psychiatric Association, Otsuka, Lundbeck, Janssen-Cilag and Pfizer. LGA has received honoraria from the 7th Framework Program European Union. LFT has received a Severo Ochoa grant (PA-17-PF-B16-179) supported by the Principado of Asturias government. CMAV has received grants from the Spanish Foundation of Psychiatry and Mental Health. PAS has been a consultant to and/or has received honoraria or grants from Adamed, CIBERSAM, European Comission, GlaxoSmithKline, Instituto de Salud Carlos III, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Plan Nacional Sobre Drogas and Servier. MPGP has been a consultant to and/or has received honoraria/grants from Angelini, Alianza Otsuka-Lundbeck, Instituto de Salud Carlos III, Janssen-Cilag, Lundbeck, Otsuka, and Pfizer. JB has received research grants and served as consultant, advisor or speaker within de last 5 years for: AB-Biotics, Acadia Pharmaceuticals, Angelini, Casen Recordati, D&A Pharma, Exeltis, Gilead, GSK, Ferrer, Indivior, Janssen-Cilag, Lundbeck, Mundipharma, Otsuka, Pfizer, Reckitt-Benckiser, Roche, Sage Therapeutics, Servier, Shire, Schwabe Farma Ibérica, research funding from the Spanish Ministry of Economy and Competiveness–Centro de Investigación Biomedica en Red area de Salud Mental (CIBERSAM) and Instituto de Salud Carlos III-, Spanish Ministry of Health, Social Services and Equality—Plan Nacional sobre Drogas—and the 7th Framework Program of the European Union. All other authors declare no competing interests.